SEC Tracker
Get the app

Dyne Therapeutics DYN

Scalzo Richard (Officer) plans to sell 1,872 DYN shares, about $22,475

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Dec 6, 2023
  2. Broker: Stifel Financial Corporation
  3. Shares acquired by: Restricted stock units granted pursuant to Issuer's 2020 Stock Incentive Plan, subject to vesting requirements
  4. 10b5-1 plan adopted: Jul 11, 2023

All of Scalzo Richard's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 681 shares at $12.01 on Dec 4, 2023 · Form 4
  • Sold 564 shares at $28.65 on Mar 1, 2024 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Dyne Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Collegium Pharmaceutical COLL public float $926M, Jun 30, 2025
  2. CorMedix CRMD public float $910M, Jun 30, 2025
  3. Harrow HROW public float $1.0B, Jun 30, 2025
  4. Geron GERN public float $861M, Jun 30, 2025
  5. Syndax Pharmaceuticals SNDX public float $799M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.